These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 200413)

  • 1. Failure of neurotransmitter blockers to alter PGE2-induced LH release.
    Jyujo T; Sato T
    Endocrinol Jpn; 1977 Aug; 23(4):281-7. PubMed ID: 200413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of neurotransmitter blockers to alter PGE2-induced LH release.
    Jyujo T; Sato T
    Endocrinol Jpn; 1976 Aug; 23(4):281-7. PubMed ID: 14822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to monoaminergic and cholinergic receptor blockers to prevent prostaglandin E2-induced luteinizing hormone release.
    Harms PG; Ojeda SR; McCann
    Endocrinology; 1976 Feb; 98(2):318-23. PubMed ID: 2457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine synthesis inhibitors acutely modulate [3H]estradiol binding by specific brain areas and pituitary in ovariectomized rats.
    Thompson MA; Woolley DE; Gietzen DW; Conway S
    Endocrinology; 1983 Sep; 113(3):855-65. PubMed ID: 6135604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic areas involved in prostaglandin (PG)-induced gonadotropin release. I: effects of PGE2 and PGF2alpha implants on luteinizing hormone release.
    Ojeda SR; Jameson HE; McCann SM
    Endocrinology; 1977 Jun; 100(6):1585-94. PubMed ID: 870307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on prostaglandin E2 (PGE2)-induced gonadotropin release: comparison with the effect of 15-methyl PGE2, PGAs, PGBs and prostaglandin endoperoxide analogs.
    Ojeda SR; Jameson HE; McCann SM
    Prostaglandins; 1976 Aug; 12(2):281, 301. PubMed ID: 959591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in LH-releasing hormone content of the hypothalamus and electron microscopy of the anterior pituitary after prostaglandin E2 injection in rats.
    Sato T; Jyujo T; Kawarai Y; Asai T
    Am J Obstet Gynecol; 1975 Jul; 122(5):637-41. PubMed ID: 1096615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cyclic AMP and LH release following prostaglandin E2 administration.
    Sato T; Jyujo T
    Prostaglandins; 1976 Dec; 12(6):1083-91. PubMed ID: 188075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of catecholamine synthesis inhibitors and adrenergic receptor antagonists on restraint-induced LH release.
    Martín AI; Fernández-Ruiz J; López-Calderón A
    J Endocrinol; 1995 Mar; 144(3):511-5. PubMed ID: 7738475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drugs which modify catecholamine activity on amplification of LH release induced by locus coeruleus electrical stimulation.
    Gitler MS; Barraclough CA
    Brain Res; 1987 Dec; 437(2):332-8. PubMed ID: 2893654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhibitors of catecholamine synthesis on the pituitary response to LH-RH.
    Rettori V; Seilicovich A; Goijman S; Debeljuk L
    Arch Androl; 1981 Mar; 6(2):151-4. PubMed ID: 6113817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandins on milk ejection.
    Vorherr H
    Endokrinologie; 1979; 74(3):257-70. PubMed ID: 232677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the medullary A1 noradrenergic system augments luteinizing hormone release induced by medial preoptic nucleus stimulation. Evaluation of A1 projections to the hypothalamus and of drugs which affect norepinephrine synthesis and adrenoceptors.
    Gitler MS; Barraclough CA
    Neuroendocrinology; 1988 Oct; 48(4):351-9. PubMed ID: 2850505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostaglandin E2, forskolin and cholera toxin on cAMP production and in vitro LH-RH release from the rat hypothalamus.
    Kim K; Ramirez VD
    Brain Res; 1986 Oct; 386(1-2):258-65. PubMed ID: 3022880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of secretion of luteinizing hormone induced by electrochemical stimulation of the anterior cingulate cortex mediated by a beta-adrenergic mechanism.
    Cáceres A; Taleisnik S
    J Endocrinol; 1980 Dec; 87(3):419-29. PubMed ID: 6256458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site of the in vivo stimulatory effect of prostaglandins on LH release.
    Drouin J; Ferland L; Bernard J; Labrie F
    Prostaglandins; 1976 Feb; 11(2):367-75. PubMed ID: 772758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for noradrenergic involvement in naloxone-induced stimulation of luteinizing hormone release in prepubertal female rats.
    Koh T; Nakai Y; Kinoshita F; Tsujii S; Tsukada T; Imura H
    Eur J Pharmacol; 1983 May; 89(3-4):275-8. PubMed ID: 6307711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of microinjection of various prostaglandins into the 3rd ventricle, median eminence and pituitary on plasma LH in rats.
    Jyujo T; Sato T; Hirono M; Igarashi M
    Endocrinol Jpn; 1976 Feb; 23(1):1-4. PubMed ID: 1278119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin-stimulated LH release in cyclic and ovariectomized rats.
    Carlson JC; Kehl SJ
    Acta Endocrinol (Copenh); 1979 Sep; 92(1):20-7. PubMed ID: 573949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies on the noradrenergic control of luteinizing hormone secretion in the domestic fowl.
    Buonomo FC; Scanes CG
    Gen Comp Endocrinol; 1983 Mar; 49(3):358-63. PubMed ID: 6132854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.